Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
Deby Fajar Mardhian(University of Twente), Jai Prakash(Radboud University Nijmegen)
Cited by 118
Related Papers
Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer
|The FASEB Journal|2017|175
SIRT1 inhibition in pancreatic cancer models: Contrasting effects in vitro and in vivo
|European Journal of Pharmacology|2015|45
FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor
|Nanotheranostics|2020|30
Apoptosis-inducing peptide loaded in PLGA nanoparticles induces anti-tumor effects in vivo
|International Journal of Pharmaceutics|2020|22